Elinor deLancey Pulcini

Original Research

An Open-Label, Proof-of-Concept Study Assessing the Effects of Bromelain-Based Enzymatic Debridement on Biofilm and Microbial Loads in Patients With Venous Leg Ulcers and Diabetic Foot Ulcers

12/20/2023

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Adam J. Singer ;

Cyaandi R. Dove , DPM;

Yaron Shoham ;

Edward Grant ;

Garth A. James ;

Aya Ben Yaakov ;

Stephen Heisler ;

Elinor deLancey Pulcini ;

Lior Rosenberg ;

Howard Petusevsky ;

This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.

This study examines the efficacy...

12/20/2023

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Elinor deLancey Pulcini

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products